Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (40832)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 28, 2017 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. Nonalcoholic fatty liver disease: Evolving paradigms. World J Gastroenterol 2017; 23(36): 6571-6592 [PMID: 29085206 DOI: 10.3748/wjg.v23.i36.6571] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i36/6571.htm |
| Number | Citing Articles |
| 1 |
Xuefeng Ma, Shousheng Liu, Jie Zhang, Mengzhen Dong, Yifen Wang, Mengke Wang, Yongning Xin. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1165-z
|
| 2 |
Linqi Guo, Wenda Jiang, Lingli Quan, Xinli Teng, Jing Zhao, Hongbin Qiu, Muhammad Muddassir Ali. Mechanism of PDZK1 in Hepatocellular Carcinoma Complicated with Hyperuricemia. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1403454
|
| 3 |
Yuanye Jiang, Xiaoyu Zhuang, Jiaqi Zhang, Meng Li, Shengnan Du, Jiyun Tian, Yifu Yuan, Guang Ji, Cheng Hu. Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1171397
|
| 4 |
M.N. Mamedov, A.K. Karimov. Secondary hyperlipidemia: features of manifestation in various somatic diseases. Profilakticheskaya meditsina 2021; 24(3): 105 doi: 10.17116/profmed202124031105
|
| 5 |
Jianjun Wang, Han Li, Xiaoyi Wang, Ruizi Shi, Junchao Hu, Xintao Zeng, Hua Luo, Pei Yang, Huiwen Luo, Yuan Cao, Xianfu Cai, Sirui Chen, Decai Wang. Association between triglyceride to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease and liver fibrosis in American adults: an observational study from the National Health and Nutrition Examination Survey 2017–2020. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1362396
|
| 6 |
Da Hea Seo, Yongin Cho, Seongha Seo, Seong Hee Ahn, Seongbin Hong, Kyung Hwa Ha, Jee-Seon Shim, Hyeon Chang Kim, Dae Jung Kim, So Hun Kim. Association between Metabolically Healthy Obesity and Subclinical Atherosclerosis in the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort. Journal of Clinical Medicine 2022; 11(9): 2440 doi: 10.3390/jcm11092440
|
| 7 |
Yun Xu, Yongfang Jiang, Yi Li. Pyrazinamide enhances lipid peroxidation and antioxidant levels to induce liver injury in rat models through PI3k/Akt inhibition. Toxicology Research 2020; 9(3): 149 doi: 10.1093/toxres/tfaa015
|
| 8 |
Rosa Zampino, Aldo Marrone, Luca Rinaldi, Barbara Guerrera, Riccardo Nevola, Adriana Boemio, Natalina Iuliano, Mauro Giordano, Nicola Passariello, Ferdinando C. Sasso, Emanuele Albano, Luigi E. Adinolfi. Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. Infection 2018; 46(6): 793 doi: 10.1007/s15010-018-1185-6
|
| 9 |
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes 2021; 9(1): 135 doi: 10.3390/pr9010135
|
| 10 |
Yuetian Yu, Yuefeng Yu, Yuying Wang, Yi Chen, Ningjian Wang, Bin Wang, Yingli Lu. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1156381
|
| 11 |
Linghan Kuang, Wei Zhou, Yongmei Jiang, Nikhil Pai. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis. PLOS ONE 2021; 16(12): e0260479 doi: 10.1371/journal.pone.0260479
|
| 12 |
Jorge Magdaleno‐Tapial, Cristian Valenzuela‐Oñate, José María Ortiz‐Salvador, Álvaro Martínez‐Doménech, Marta García‐Legaz‐Martínez, Miriam Alonso‐Carpio, Juan José Tamarit‐García, Moisés Diago‐Madrid, José Luis Sánchez‐Carazo, Amparo Pérez‐Ferriols. Prevalence of non‐alcoholic fatty liver and liver fibrosis in patients with moderate–severe psoriasis: A cross‐sectional cohort study . Australasian Journal of Dermatology 2020; 61(2): 105 doi: 10.1111/ajd.13175
|
| 13 |
Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Lisa B. VanWagner, James G. Terry, Mark A. Pereira. Non‐alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study. Obesity Science & Practice 2024; 10(2) doi: 10.1002/osp4.751
|
| 14 |
Mayra Domínguez‐Pérez, Arturo Simoni‐Nieves, Patricia Rosales, Natalia Nuño‐Lámbarri, Mónica Rosas‐Lemus, Verónica Souza, Roxana U. Miranda, Leticia Bucio, Salvador Uribe Carvajal, Jens U. Marquardt, Daekwan Seo, Luis E. Gomez‐Quiroz, María Concepción Gutiérrez‐Ruiz. Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis. Journal of Cellular Physiology 2019; 234(5): 7213 doi: 10.1002/jcp.27474
|
| 15 |
Luca Rinaldi, Maria Guarino, Alessandro Perrella, Pia Clara Pafundi, Giovanna Valente, Luca Fontanella, Riccardo Nevola, Barbara Guerrera, Natalina Iuliano, Michele Imparato, Alessio Trabucco, Ferdinando Carlo Sasso, Filomena Morisco, Antonio Ascione, Guido Piai, Luigi Elio Adinolfi. Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience. Digestive Diseases and Sciences 2019; 64(10): 3013 doi: 10.1007/s10620-019-05604-8
|
| 16 |
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular Disease. Contemporary Cardiology 2021; : 141 doi: 10.1007/978-3-030-62632-7_9
|
| 17 |
Ye Lu, Lili Hu, Jing Song, Jing Wan, Haibing Chen, Jun Yin. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00899-z
|
| 18 |
Kiarash Riazi, Hassan Azhari, Jacob H Charette, Fox E Underwood, James A King, Elnaz Ehteshami Afshar, Mark G Swain, Stephen E Congly, Gilaad G Kaplan, Abdel-Aziz Shaheen. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2022; 7(9): 851 doi: 10.1016/S2468-1253(22)00165-0
|
| 19 |
Anshul Sharma, Hae-Jeung Lee. A Review on the Protecting Effects and Molecular Mechanisms of Berries Against a Silent Public Health Concern: Non-Alcoholic Fatty Liver Disease. Antioxidants 2024; 13(11): 1389 doi: 10.3390/antiox13111389
|
| 20 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
|
| 21 |
Nada Abedin, Andrea Tannapfel, Peter J. Wild, Iris Tischoff. Histopathologische Evaluierung der nichtalkoholischen Fettleber. Der Pathologe 2022; 43(2): 157 doi: 10.1007/s00292-022-01052-w
|
| 22 |
Muraly Puttabyatappa, Jacob D. Martin, Victoria Andriessen, Micaela Stevenson, Lixia Zeng, Subramaniam Pennathur, Vasantha Padmanabhan. Developmental programming: Changes in mediators of insulin sensitivity in prenatal bisphenol A-treated female sheep. Reproductive Toxicology 2019; 85: 110 doi: 10.1016/j.reprotox.2019.03.002
|
| 23 |
Pegah Golabi, James Paik, Rashmi Reddy, Elisabetta Bugianesi, Gregory Trimble, Zobair M. Younossi. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0972-6
|
| 24 |
Nicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, Sonja M. Kessler, Julia Unterluggauer, Stefanie Krassnig, Kensuke Kojima, Xintong Chen, Yujin Hoshida, Nabeel M. Bardeesy, Heimo Müller, Vendula Svendova, Michael G. Schimek, Clemens Diwoky, Alexandra Lipfert, Vineet Mahajan, Cornelia Stumptner, Andrea Thüringer, Leopold F. Fröhlich, Tatjana Stojakovic, K.P.R. Nilsson, Thomas Kolbe, Thomas Rülicke, Thomas M. Magin, Pavel Strnad, Alexandra K. Kiemer, Richard Moriggl, Johannes Haybaeck. High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype. Translational Oncology 2019; 12(2): 256 doi: 10.1016/j.tranon.2018.10.010
|
| 25 |
Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of view. Exploration of Medicine 2020; 1(3): 85 doi: 10.37349/emed.2020.00007
|
| 26 |
Yao Zhang, Kongdong Li, Anqi Kong, Yang Zhou, Dongfeng Chen, Jie Gu, Haifeng Shi. Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants. Ecotoxicology and Environmental Safety 2021; 217: 112256 doi: 10.1016/j.ecoenv.2021.112256
|
| 27 |
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. Medicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
|
| 28 |
Jeffrey B. Ames, Maya Djerboua, Norah A. Terrault, Christopher M. Booth, Jennifer A. Flemming, Kevork M. Peltekian. Rising Healthcare Costs and Utilization among Young Adults with Cirrhosis in Ontario: A Population-Based Study. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/6175913
|
| 29 |
Nada Abedin, Andrea Tannapfel, Peter J. Wild, Iris Tischoff. Histopathologische Evaluierung der nichtalkoholischen Fettleber. Wiener klinisches Magazin 2022; 25(4): 146 doi: 10.1007/s00740-022-00444-1
|
| 30 |
Zhigang Wang, Hui Zhao, Qian Zhou, Yuvaraja Teekaraman. Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6818888
|
| 31 |
Amedeo Lonardo, Ayako Suzuki. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. Journal of Clinical Medicine 2020; 9(5): 1278 doi: 10.3390/jcm9051278
|
| 32 |
Guilherme Moura Cunha, Patrick J Navin, Kathryn J Fowler, Sudhakar K Venkatesh, Richard L Ehman, Claude B Sirlin. Quantitative magnetic resonance imaging for chronic liver disease. The British Journal of Radiology 2021; 94(1121) doi: 10.1259/bjr.20201377
|
| 33 |
Virginia Esteve-Luque, Ariadna Padró-Miquel, Marta Fanlo-Maresma, Emili Corbella, Xavier Corbella, Xavier Pintó, Beatriz Candás-Estébanez. Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia. Nutrients 2021; 13(2): 552 doi: 10.3390/nu13020552
|
| 34 |
Qian Chen, Mengyang Liu, Haiyang Yu, Jian Li, Sijian Wang, Yi Zhang, Feng Qiu, Tao Wang. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway. Journal of Natural Medicines 2018; 72(3): 655 doi: 10.1007/s11418-018-1199-5
|
| 35 |
Massoud Houshmand, Vahide Zeinali, Amirhossein Hosseini, Atena Seifi, Bardia Danaei, Sharareh Kamfar. Investigation of FGF21 mRNA levels and relative mitochondrial DNA copy number levels and their relation in nonalcoholic fatty liver disease: a case-control study. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1203019
|
| 36 |
Yunxiao Gao, Rongrong Tian, Haiyue Liu, Huimin Xue, Ruizhe Zhang, Suping Han, Lin Ji, Weidong Huang, Jicheng Zhan, Yilin You. Research progress on intervention effect and mechanism of protocatechuic acid on nonalcoholic fatty liver disease. Critical Reviews in Food Science and Nutrition 2022; 62(32): 9053 doi: 10.1080/10408398.2021.1939265
|
| 37 |
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
|
| 38 |
Teodora Barbalata, Mariana Deleanu, Mihaela Georgiana Carnuta, Loredan Stefan Niculescu, Mina Raileanu, Anca Volumnia Sima, Camelia Sorina Stancu. Hyperlipidemia Determines Dysfunctional HDL Production and Impedes Cholesterol Efflux in the Small Intestine: Alleviation by Ginger Extract. Molecular Nutrition & Food Research 2019; 63(19) doi: 10.1002/mnfr.201900029
|
| 39 |
Guifen Zhao, Ran'geng Shi, Mao Ma, Hairong Lin, Jianqin Zhang, Binwu Sheng. Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102363 doi: 10.1016/j.clinre.2024.102363
|
| 40 |
Yuanyuan Meng, Yong Liu, Ningning Fang, Yongmin Guo. Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat. Pharmaceutical Biology 2019; 57(1): 98 doi: 10.1080/13880209.2019.1568509
|
| 41 |
Tomislav Kizivat, Ivana Maric, Dunja Mudri, Ines Bilic Curcic, Dragan Primorac, Martina Smolic. Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00027
|
| 42 |
M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, P. Tsarkova, C. Marinova, D. Popov, L. Mateva, T. Tankova. Metabolic determinants of NAFLD in adults with type 1 diabetes. Diabetes Research and Clinical Practice 2022; 186: 109819 doi: 10.1016/j.diabres.2022.109819
|
| 43 |
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto. Screening strategy for non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 2023; 29(Suppl): S103 doi: 10.3350/cmh.2022.0336
|
| 44 |
Lorena Fecury Tavares, Mariana Rosa Bernardo, Kalil Orleans Silveira Pinho, Ana Paula Santos Oliveira Brito, Rodrigo Bona Maneschy, Hamilton Cezar Rocha de Garcia. Doença Hepática Gordurosa Não Alcoólica - Diagnóstico e tratamento. Pará Research Medical Journal 2022; 3(2): 1 doi: 10.4322/prmj.2019.011
|
| 45 |
Faisal M Sanai, Faisal Abaalkhail, Fuad Hasan, Muhammad Hamed Farooqi, Nawal Al Nahdi, Zobair M Younossi. Management of nonalcoholic fatty liver disease in the Middle East. World Journal of Gastroenterology 2020; 26(25): 3528-3541 doi: 10.3748/wjg.v26.i25.3528
|
| 46 |
Guohong Qin, Ji Ma, Qiongshan Huang, Hongli Yin, Jichun Han, Maoru Li, Yang Deng, Bing Wang, Waseem Hassan, Jing Shang. Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model. International Journal of Molecular Sciences 2018; 19(12): 4126 doi: 10.3390/ijms19124126
|
| 47 |
Lixiang Fu, Wenyue Zhang, Yupei Ao, Zhongling Zheng, Huaidong Hu. Efficacy of aerobic and resistance exercises in improving visceral adipose in patients with non-alcoholic fatty liver: a meta-analysis of randomized controlled trials. Zeitschrift für Gastroenterologie 2022; 60(11): 1644 doi: 10.1055/a-1742-4257
|
| 48 |
Rourke D. Decker, Eric M. Ghiraldi, Alexandra H. Weiss, John P. Gaughan, Justin I. Friedlander. Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III. Journal of Endourology 2020; 34(12): 1258 doi: 10.1089/end.2020.0486
|
| 49 |
Andre Fialho, Andrea Fialho, Bruno Ribeiro, Miguel Malespin, Silvio De Melo, Ron Schey, Peter Ghali. Association Between Helicobacter pylori and Steatosis Severity on Transient Elastography . Cureus 2023; doi: 10.7759/cureus.34042
|
| 50 |
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
|
| 51 |
Madan Kumar Arumugam, Matthew C. Paal, Terrence M. Donohue, Murali Ganesan, Natalia A. Osna, Kusum K. Kharbanda. Beneficial Effects of Betaine: A Comprehensive Review. Biology 2021; 10(6): 456 doi: 10.3390/biology10060456
|
| 52 |
Priyankar Dey, Bryan D. Olmstead, Geoffrey Y. Sasaki, Yael Vodovotz, Zhongtang Yu, Richard S. Bruno. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota. The Journal of Nutritional Biochemistry 2020; 84: 108455 doi: 10.1016/j.jnutbio.2020.108455
|
| 53 |
Shahinul Alam, Mahbuba Kawser, Saif Uddin Nisar Ahmed, Md Mahabubul Alam, Md Saiful Islam, Shayla Nasrin. Longer sitting times and bulk amounts of rice intake are associated with the increased risks of metabolic dysfunction-associated fatty liver diseases (MAFLD): A case-control study. Clinical Nutrition Open Science 2024; 58: 275 doi: 10.1016/j.nutos.2024.10.002
|
| 54 |
Reyhane Ebrahimi, Parvin Pasalar, Hajar Shokri, Maryam Shabani, Solaleh Emamgholipour. Evidence for the effect of soluble uric acid in augmenting endoplasmic reticulum stress markers in human peripheral blood mononuclear cells. Journal of Physiology and Biochemistry 2022; 78(2): 343 doi: 10.1007/s13105-021-00869-y
|
| 55 |
Anita Morandi, Anna Di Sessa, Chiara Zusi, Giuseppina Rosaria Umano, Dania El Mazloum, Elena Fornari, Emanuele Miraglia del Giudice, Giovanni Targher, Claudio Maffeis. Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis. The Journal of Clinical Endocrinology & Metabolism 2020; 105(11): e4046 doi: 10.1210/clinem/dgaa583
|
| 56 |
Hayat Mohamed Suliman, Bashier Osman, Iman H. Abdoon, Amir Mustafa Saad, Hassan Khalid. Ameliorative activity of Adansonia digitata fruit on high sugar/high fat diet-simulated Metabolic Syndrome model in male Wistar rats. Biomedicine & Pharmacotherapy 2020; 125: 109968 doi: 10.1016/j.biopha.2020.109968
|
| 57 |
Manu V. Chakravarthy, Brent A. Neuschwander‐Tetri. The metabolic basis of nonalcoholic steatohepatitis. Endocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.112
|
| 58 |
Antonio T. Pinto, Veronika Lukacs-Kornek. The role of dendritic cells in MASH: friends or foes?. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1379225
|
| 59 |
Shou-Sheng Liu, Xue-Feng Ma, Jie Zhao, Shui-Xian Du, Jie Zhang, Meng-Zhen Dong, Yong-Ning Xin. Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01288-6
|
| 60 |
Prashasti Gupta. Non-alcohlic Fatty Liver Disease (NAFLD): Is it a Dormant Volcano or Tip of an Iceberg?. Indian Journal of Community Medicine 2024; 49(6): 780 doi: 10.4103/ijcm.ijcm_174_24
|
| 61 |
Lijuan Li, Kun Hou, Mengya Yuan, Yan Zhang, Yang Zhang. Change lifestyle modification plan/transtheoretical model in non-alcoholic simple fatty liver disease: a pilot randomized study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02506-4
|
| 62 |
Ling-Yan Yu, Wei-Ying Li, Jia Lin. Juglanin improves lipid metabolism disorder, liver injury, and intestinal integrity in nonalcoholic fatty liver mice. World Chinese Journal of Digestology 2020; 28(4): 113 doi: 10.11569/wcjd.v28.i4.113
|
| 63 |
AshrafG Dala, El-ArabA. A. Ezz, AhmedK. Abd Elaziz Ewida. The relationship between nonalcoholic fatty liver disease and cancers. Menoufia Medical Journal 2021; 34(2): 409 doi: 10.4103/mmj.mmj_312_19
|
| 64 |
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li. Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Medicinal Research Reviews 2019; 39(1): 328 doi: 10.1002/med.21515
|
| 65 |
Maddi Oses, María Medrano, Javier Margareto Sanchez, Maria P. Portillo, Concepcion Maria Aguilera, Signe Altmäe, Idoia Labayen. Peripheral blood mononuclear cells‐expressed miRNA profiles derived from children with metabolic‐associated fatty liver disease and insulin resistance. Pediatric Obesity 2022; 17(12) doi: 10.1111/ijpo.12966
|
| 66 |
Vikram K. Mahajan, Narvir S. Chauhan, Baldev S. Rana, Karaninder S. Mehta, Sheenam Hooda, Pushpinder S. Chauhan, Amisha Kukreja. The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study. Journal of Clinical and Experimental Hepatology 2022; 12(3): 785 doi: 10.1016/j.jceh.2021.11.016
|
| 67 |
David Romero‐Pérez, Isabel Belinchón‐Romero, Pablo Bellot, Rubén Francés, Francisco Marco, Jose Manuel Ramos‐Rincón. Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk. Australasian Journal of Dermatology 2019; 60(4) doi: 10.1111/ajd.13098
|
| 68 |
Chiao-Lin Hsu, Fu-Zong Wu, Kung-Hung Lin, Yu-Hsun Chen, Pin-Chieh Wu, Yan-Hua Chen, Chi-Shen Chen, Wen-Hwa Wang, Guang-Yuan Mar, Hsien-Chung Yu. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup. Clinical and Translational Gastroenterology 2019; 10(5): e00042 doi: 10.14309/ctg.0000000000000042
|
| 69 |
Elena-Daniela Grigorescu, Mariana Floria, Cristina Mihaela Lăcătușu, Bogdan Mircea-Mihai, Ioana Creţu, Alina Delia Popa, Alina Onofriescu, Irina M. Jaba, Victoriţa Șorodoc, Alexandr Ceasovschih, Laurenţiu Șorodoc. The Relationship between Hepatic Steatosis, inflammation and insulin Resistance in type 2 Diabetes with Metabolic Imbalance. Internal Medicine 2019; 16(4): 13 doi: 10.2478/inmed-2019-0073
|
| 70 |
Yan Chen, Chuan Lu, Haonan Ju, Qingzhi Zhou, Xin Zhao. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017–2018. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1405828
|
| 71 |
Guotai Sheng, Qiyang Xie, Rongsheng Wang, Chong Hu, Mingchun Zhong, Yang Zou. Waist-to-height ratio and non-alcoholic fatty liver disease in adults. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01824-3
|
| 72 |
Anjana Reddy, Paul Della Gatta, Shaun Mason, Amanda J. Nicoll, Marno Ryan, Catherine Itsiopoulos, Gavin Abbott, Nathan A. Johnson, Siddharth Sood, Stuart K. Roberts, Elena S. George, Audrey C. Tierney. Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: The MEDINA randomized controlled trial. Nutrition Research 2023; 119: 98 doi: 10.1016/j.nutres.2023.09.005
|
| 73 |
Heechul Nam, Jeong-Ju Yoo, Yuri Cho, Seong Hee Kang, Sang Bong Ahn, Hye-Won Lee, Dae Won Jun, Do Seon Song, Miyoung Choi. Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis. Digestive and Liver Disease 2023; 55(9): 1178 doi: 10.1016/j.dld.2022.12.013
|
| 74 |
Toshihiro Umehara, Giovanni Targher. Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults. PLOS ONE 2018; 13(6): e0197900 doi: 10.1371/journal.pone.0197900
|
| 75 |
Luigi Mirarchi, Simona Amodeo, Roberto Citarrella, Anna Licata, Maurizio Soresi, Lydia Giannitrapani. SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(7): 3668 doi: 10.3390/ijms23073668
|
| 76 |
Laura Cano-Lallave, Jaime Ruiz-Tovar, Lucia Martin-de-Bernardo, Malena Martinez-Oribe, Cristina Rodriguez-Obispo, Sara Carrascosa-Corrochano, Ana Martín-Nieto, Isabel Baeza, Marta Gonzalez-Ramos, Marta Benito, Isabel Olazabal. Influence of Adherence to the Mediterranean Diet and Level of Physical Activity with Liver Steatosis in People Aged > 50 Years and with a BMI > 25 kg/m2: Association with Biochemical Markers. Nutrients 2024; 16(13): 1996 doi: 10.3390/nu16131996
|
| 77 |
Rajvi Gor, Nabeel A Siddiqui, Ransirini Wijeratne Fernando, Archana Sreekantan Nair, Janan Illango, Mushrin Malik, Pousette Hamid. Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current Stand. Cureus 2021; doi: 10.7759/cureus.14858
|
| 78 |
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Annals of Hepatology 2020; 19(4): 359 doi: 10.1016/j.aohep.2020.03.001
|
| 79 |
Jinxiu Li, Shang Wang, Ling Yao, Peng Ma, Zhiwei Chen, Ting-Li Han, Chunlin Yuan, Jun Zhang, Lirong Jiang, Li Liu, Dazhi Ke, Chunli Li, Johji Yamahara, Yuhao Li, Jianwei Wang. 6-gingerol ameliorates age-related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction. Toxicology and Applied Pharmacology 2019; 362: 125 doi: 10.1016/j.taap.2018.11.001
|
| 80 |
Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo. Extra-Hepatic Manifestations and Complications of Nonalcoholic Fatty Liver Disease. Future Medicinal Chemistry 2019; 11(16): 2171 doi: 10.4155/fmc-2019-0003
|
| 81 |
Huicui Liu, Chenxi Nie, Xinzhong Hu, Juxiu Li. Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota. Food & Function 2024; 15(3): 1250 doi: 10.1039/D3FO03386D
|
| 82 |
Luca Rinaldi, Veronica Folliero, Luciana Palomba, Carla Zannella, Rachele Isticato, Raffaele Di Francia, Massimiliano Berretta, Ilario de Sio, Luigi E. Adinolfi, Giancarlo Morelli, Secondo Lastoria, Lucia Altucci, Carlo Pedone, Massimiliano Galdiero, Gianluigi Franci. Sonoporation by microbubbles as gene therapy approach against liver cancer. Oncotarget 2018; 9(63): 32182 doi: 10.18632/oncotarget.25875
|
| 83 |
N. A. Cherkashchenko, M. A. Livzan, T. S. Krolevets. Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2020; 92(2): 48 doi: 10.26442/00403660.2020.02.000550
|
| 84 |
Ricardo Amorim, Pedro Soares, Daniel Chavarria, Sofia Benfeito, Fernando Cagide, José Teixeira, Paulo J. Oliveira, Fernanda Borges. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities. European Journal of Medicinal Chemistry 2024; 277: 116723 doi: 10.1016/j.ejmech.2024.116723
|
| 85 |
Amedeo Lonardo. Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?. Journal of Clinical Medicine 2021; 10(3): 492 doi: 10.3390/jcm10030492
|
| 86 |
Monika Yadav, Nar Singh Chauhan. Role of gut-microbiota in disease severity and clinical outcomes. Briefings in Functional Genomics 2024; 23(1): 24 doi: 10.1093/bfgp/elac037
|
| 87 |
Sahar H. Elhini, Engy A. Wahsh, Ahmed A. Elberry, Nadia F. El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, Hoda M. Rabea. The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals 2022; 15(12): 1516 doi: 10.3390/ph15121516
|
| 88 |
Yan Wang, Fangli Zhou, Siyi Shu, Yunhong Wu, Haoming Tian, Yujue Li, Xiang Chen. In vitro osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice. Biochemistry and Biophysics Reports 2024; 39: 101788 doi: 10.1016/j.bbrep.2024.101788
|
| 89 |
Sheila Maier, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan, Miguel A. Lanaspa, Richard J. Johnson, Thomas Jensen. Lean NAFLD: an underrecognized and challenging disorder in medicine. Reviews in Endocrine and Metabolic Disorders 2021; 22(2): 351 doi: 10.1007/s11154-020-09621-1
|
| 90 |
Yong Zhang, Jie Xu, Di Zhou, Tingting Ye, Puqing Zhou, Zuofeng Liu, Xinyuan Liu, Zinan Wang, Tianmiao Hua, Zhenghao Zhang, Qingyan Sun. Swimming exercise ameliorates insulin resistance and nonalcoholic fatty liver by negatively regulating PPARγ transcriptional network in mice fed high fat diet. Molecular Medicine 2023; 29(1) doi: 10.1186/s10020-023-00740-4
|
| 91 |
Tatiana R. Romantsova, Yulia P. Sych. Immunometabolism and metainflammation in obesity. Obesity and metabolism 2019; 16(4): 3 doi: 10.14341/omet12218
|
| 92 |
Jonathan G. Stine, Christopher Soriano, Ian Schreibman, Gloriany Rivas, Breianna Hummer, Esther Yoo, Kathryn Schmitz, Christopher Sciamanna. Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2021; 66(10): 3604 doi: 10.1007/s10620-020-06673-w
|
| 93 |
Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. Diabetes, Metabolic Syndrome and Obesity 2023; : 3303 doi: 10.2147/DMSO.S431251
|
| 94 |
Ehimen C. Aneni, Gul Jana Saeed, Marcio Sommer Bittencourt, Miguel Cainzos-Achirica, Chukwuemeka U. Osondu, Matthew Budoff, Edison R. Parise, Raul D. Santos, Khurram Nasir, Martin Senechal. Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals. PLOS ONE 2022; 17(4): e0266505 doi: 10.1371/journal.pone.0266505
|
| 95 |
Simonetta Lugari, Alessandro Mantovani, Fabio Nascimbeni, Amedeo Lonardo. Hypothyroidism and nonalcoholic fatty liver disease – a chance association?. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2018-0047
|
| 96 |
Yang Zhang, Jun-Xiang Li, Yan Zhang, Yun-Liang Wang. Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis . World Journal of Clinical Cases 2021; 9(23): 6654-6662 doi: 10.12998/wjcc.v9.i23.6654
|
| 97 |
Jaime Ruiz-Tovar, Lorea Zubiaga. Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomy. Surgery for Obesity and Related Diseases 2019; 15(9): 1447 doi: 10.1016/j.soard.2019.05.004
|
| 98 |
Mamun Al Mahtab, Jhumur Ghosh, Shobna Bhatia, Aabha Nagral, Manisha Bangar, Sherna Menezes, Nazish Butt, Jayani Harshika Manchanayake, Shivaram Prasad Singh. Gender Differences in Nonalcoholic Fatty Liver Disease. Euroasian Journal of Hepato-Gastroenterology 2022; 12(S1): S19 doi: 10.5005/jp-journals-10018-1370
|
| 99 |
Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena. Liver Research 2022; 6(2): 72 doi: 10.1016/j.livres.2022.05.002
|
| 100 |
Kiarash Riazi, Hassan Azhari, Jacob H. Charette, Fox E. Underwood, James A. King, Elnaz Ehteshami Afshar, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel Aziz Shaheen. The Worldwide Burden of NAFLD: A Systematic Review and Meta-Analysis of Prevalence and Incidence. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4002396
|
| 101 |
Fan Zheng, Ying Cai. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-018-0933-z
|
| 102 |
Sergey GUSHCHA, Natalia DRAGOMIRETSKA, Iryna ZABOLOTNA, Boris NASIBULLIN, Anna IZHA, Natalia ВADIUK, Khrystyna KOIEVA, Constantin MUNTEANU. Possibilities of using natural mineral waters in the treatment of patients with non-alcoholic fatty liver disease. Balneo Research Journal 2019; 10(Vol 10 No. 4): 450 doi: 10.12680/balneo.2019.280
|
| 103 |
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Kourosh Kazemi, Alireza Shamsaeefar, Seyed Ali Malek-Hosseini. Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid. Clinics and Research in Hepatology and Gastroenterology 2020; 44(4): 572 doi: 10.1016/j.clinre.2019.09.002
|
| 104 |
Niki Katsiki, Michael Doumas, Vasilios Athyros. Metabolic syndrome: joint diagnostic criteria and links with comorbidities. Hormones 2019; 18(1): 107 doi: 10.1007/s42000-018-0074-9
|
| 105 |
Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi, Riccardo Nevola, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin. Exploration of Medicine 2020; 1(5) doi: 10.37349/emed.2020.00019
|
| 106 |
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi, Amedeo Lonardo. Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. Atherosclerosis 2019; 284: 66 doi: 10.1016/j.atherosclerosis.2019.02.028
|
| 107 |
Shirin Pourteymour, Christian A. Drevon, Knut Tomas Dalen, Frode A. Norheim. Mechanisms Behind NAFLD: a System Genetics Perspective. Current Atherosclerosis Reports 2023; 25(11): 869 doi: 10.1007/s11883-023-01158-3
|
| 108 |
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Maria Vittoria Morone, Chiara Silvestri, Mauro Giordano, Teresa Salvatore, Ferdinando Carlo Sasso. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review. Antioxidants 2021; 10(2): 270 doi: 10.3390/antiox10020270
|
| 109 |
Howell Leung, Xiaoxue Long, Yueqiong Ni, Lingling Qian, Emmanouil Nychas, Sara Leal Siliceo, Dennis Pohl, Kati Hanhineva, Yan Liu, Aimin Xu, Henrik B. Nielsen, Eugeni Belda, Karine Clément, Rohit Loomba, Huating Li, Weiping Jia, Gianni Panagiotou. Risk assessment with gut microbiome and metabolite markers in NAFLD development. Science Translational Medicine 2022; 14(648) doi: 10.1126/scitranslmed.abk0855
|
| 110 |
Zobair M. Younossi, Maria Stepanova, Janus Ong, Greg Trimble, Saleh AlQahtani, Issah Younossi, Aijaz Ahmed, Andrei Racila, Linda Henry. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States. Clinical Gastroenterology and Hepatology 2021; 19(3): 580 doi: 10.1016/j.cgh.2020.05.064
|
| 111 |
Simona Cernea, Itamar Raz. NAFLDin type 2 diabetes mellitus: Still many challenging questions. Diabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
|
| 112 |
Preya Janubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Nigel Neil Brown, Nivene Saad, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, Anthony William Russell, Elizabeth Ellen Powell. Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. Journal of Diabetes and its Complications 2018; 32(8): 799 doi: 10.1016/j.jdiacomp.2018.05.008
|
| 113 |
Stefano Bellentani, Giorgio Bedogni, Claudio Tiribelli. Two drinks per day does not take your fatty liver away. Hepatology 2018; 67(6): 2072 doi: 10.1002/hep.29753
|
| 114 |
Si-Qin Long, Xiu-Feng Yu, Yu-Li Ge, Lu-Xiang Liu. Ginkgolide B ameliorates high-fat diet-induced hepatic steatosis and inflammation in mice. World Chinese Journal of Digestology 2020; 28(13): 519 doi: 10.11569/wcjd.v28.i13.519
|
| 115 |
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, review. Annals of Medicine and Surgery 2020; 50: 41 doi: 10.1016/j.amsu.2020.01.001
|
| 116 |
Shufei Zang, Jin Chen, Yu Song, Lang Bai, Jinjun Chen, Xiaoling Chi, Fangping He, Huiping Sheng, Jing Wang, Shilong Xie, Wen Xie, Yongfeng Yang, Jing Zhang, Minghua Zheng, Zhengsheng Zou, Bingyuan Wang, Junping Shi. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design. Advances in Therapy 2018; 35(2): 218 doi: 10.1007/s12325-018-0670-8
|
| 117 |
国洪 杨. Research Progress on Co-Pathogenesis of Non-Alcoholic Fatty Liver Disease and Sarcopenia. Advances in Clinical Medicine 2024; 14(04): 1682 doi: 10.12677/acm.2024.1441210
|
| 118 |
|
| 119 |
Katsumi Iizuka. Dietary Interventions in Liver Disease. 2019; : 263 doi: 10.1016/B978-0-12-814466-4.00022-7
|
| 120 |
Flavio A. Cadegiani. Dietary Interventions in Liver Disease. 2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
|
| 121 |
Tomoe Kinoshita, Masashi Shimoda, Koji Nakashima, Yoshiro Fushimi, Yurie Hirata, Akihito Tanabe, Fuminori Tatsumi, Hidenori Hirukawa, Junpei Sanada, Kenji Kohara, Shintaro Irie, Tomohiko Kimura, Yoshiko Nakamura, Momoyo Nishioka, Atsushi Obata, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto. Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control study. Journal of Diabetes Investigation 2020; 11(6): 1612 doi: 10.1111/jdi.13279
|
| 122 |
Mattia Bellan, Cosimo Colletta, Matteo Nazzareno Barbaglia, Livia Salmi, Roberto Clerici, Venkata Ramana Mallela, Luigi Mario Castello, Giuseppe Saglietti, Gian Piero Carnevale Schianca, Rosalba Minisini, Mario Pirisi. Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms. Diabetes & Metabolism Journal 2019; 43(5): 700 doi: 10.4093/dmj.2018.0201
|
| 123 |
T. Karlas. Diagnose und Verlaufsbeurteilung von Fettlebererkrankungen. Der Gastroenterologe 2018; 13(4): 272 doi: 10.1007/s11377-018-0263-8
|
| 124 |
Daniel G Tenen, Li Chai, Justin L Tan. Metabolic alterations and vulnerabilities in hepatocellular carcinoma. Gastroenterology Report 2021; 9(1): 1 doi: 10.1093/gastro/goaa066
|
| 125 |
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, Olivera Stanojlović, Djuro Macut, Dušan Mladenović. The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach. Current Issues in Molecular Biology 2023; 45(11): 9084 doi: 10.3390/cimb45110570
|
| 126 |
Mina Movahedian, Jamal Rahmani, Seyed Saeed Hashemi Nazari, Susan Mohamadi, Gurudatta Naik, Azita Hekmatdoost. Fatty liver index and risk of diabetes incidence: A systematic review and dose-response meta-analysis of cohort studies. Primary Care Diabetes 2020; 14(6): 577 doi: 10.1016/j.pcd.2020.02.011
|
| 127 |
Eda Kaya, Yusuf Yilmaz. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. Journal of Clinical and Translational Hepatology 2022; 10(2): 329 doi: 10.14218/JCTH.2021.00178
|
| 128 |
Liu Li, Li Yang, Feng Yang, Xin-lan Zhao, Shengjiang Xue, Fang-hua Gong. Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice. Journal of Inflammation Research 2021; : 1959 doi: 10.2147/JIR.S302934
|
| 129 |
Zhibo Zhao, Li Zhong, Peizhi Li, Kun He, Chan Qiu, Lei Zhao, Jianping Gong. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p. Experimental Cell Research 2020; 387(1): 111738 doi: 10.1016/j.yexcr.2019.111738
|
| 130 |
Mahak Arora, Nikolina Kutinová Canová, Hassan Farghali. mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis. European Journal of Pharmacology 2022; 921: 174857 doi: 10.1016/j.ejphar.2022.174857
|
| 131 |
Karla Sawada Toda-Oti, José Tadeu Stefano, Ana Mercedes Cavaleiro, Flair José Carrilho, Maria Lúcia Correa-Gianella, Cláudia Pinto Marques de Souza de Oliveira. Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian Patients. Metabolic Syndrome and Related Disorders 2022; 20(2): 114 doi: 10.1089/met.2020.0104
|